Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21
2006; Elsevier BV; Volume: 51; Issue: 2 Linguagem: Inglês
10.1016/j.neuropharm.2006.03.029
ISSN1873-7064
AutoresFrancisco Javier Pavón, Ainhoa Bilbao, Laura Hernández‐Folgado, Andrea Cippitelli, Nadine Jagerovic, Gumersindo Abellán, Marı́a Isabel Rodrı́guez-Franco, Antonia Serrano, Manuel Macías, Raquel Gómez de Heras, Miguel Navarro, Pilar Goya, Fernando Rodrı́guez de Fonseca,
Tópico(s)Forensic Toxicology and Drug Analysis
Referência(s)